| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TNFSF13 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | ETV5 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | LINC00998 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | GPRC5D | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | CR1L | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | CAB39L | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | ARHGEF4 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | STX12 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | FBXO32 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | KHDC1L | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
